29 May 2025
  • Blog
  • About
  • Contact
   
  • Current Topics
  • Social Media
  • Innovation
  • Medical Education
  • Residency
  • Research
Headline News
  • Doctors Day 2020 – Anything But Happy 31 Mar 2020
  • Social Media and Professionalism – Protecting Your Patients, Your Profession, and You 30 Oct 2018
  • Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match 24 Oct 2018
  • The Retina Society – 2018 Meeting Highlights 15 Sep 2018
  • Vitreoretinal Fellowship Match Survey – JAMA Ophthalmology 07 May 2018
  • home
  • blog
Retinal Artery Macroaneurysm (RAMA)

Retinal Artery Macroaneurysm (RAMA)

25 Nov 2017 eyesteve 0 12925

In this post (and video!) I briefly discuss the key features, diagnosis, and treatment of retinal artery macroaneurysms, more commonly known as RAMA.

The clinical picture in this vignette is of an 80 year-old hypertensive Caucasian woman who presented to our urgent clinic with new-onset floaters. Her vision was 20/250 in the left eye, and the anterior segment examination was normal.

This is a fundus photo of the left eye, which shows a slightly hazy view due to vitreous hemorrhage. Along the superior vascular arcade you see a discrete area of deep, subretinal hemorrhage with a white spot in the center, and perhaps some pre-retinal hemorrhage just anterior to this white area. Based on her history and these exam findings, it was suspected that she had a retinal artery macroaneurysm.

She returned two and a half months later, and her vision had returned to 20/20, with resolution of the vitreous and subretinal hemorrhage, but persistence of the yellowish macroaneurysm.

Let’s review some important features of retinal artery macroaneurysms.

RAMAs are round dilations, or aneurysms, of retinal arterioles. They most commonly affect women in their sixth decade of life, or later. They typically occur in just one eye and within the first three branches of the superotemporal retinal arteriole. The pathogenesis is not known, though one theory is that systemic arteriosclerosis causes fibrosis within the wall of the vessel. The resulting decreased elasticity, coupled with systemic hypertension leads to development of the aneurysm.

If the macroaneurysm ruptures, hemorrhage can be seen at multiple levels, as can be seen in this photo of a different patient, in this case an 88 year-old, hypertensive woman who I also believed had a RAMA. You can see that the view is hazy due to dispersed vitreous hemorrhage. You can also see an area of likely preretinal hemorrhage centrally, and surrounding deep, subretinal hemorrhage.

When this patient returned three weeks later, much of the vitreous and subretinal hemorrhage had resolved, but significant exudate remained, with subretinal fluid now involving the macula, which you can see on this OCT.

A fluorescein angiogram was performed, but unfortunately did not clearly photograph the macroaneurysm. Let me show you some wonderful FA photos of RAMA from the University of Iowa. Here you see a fundus photo of the right eye showing a large area of subretinal hemorrhage, with hemorrhage extending into the macula, and a small amount of preretinal hemorrhage. Note the white spot along the superotemporal artery which corresponds to the hyperfluorescent lesion in the angiogram.

Photo courtesy EyeRounds.org

Here, in the midvenous phase, there is increased hyperfluorescence, which persists in the late phase seen also seen below.

Photo courtesy EyeRounds.org

Because the majority of macroaneurysms involute spontaneously, most patients can be safely observed without treatment, though hypertension and other vascular risk factors should be controlled as much as possible. Treatment options include laser photocoagulation or, especially in recent years, intravitreal anti-VEGF injections for macula-involving subretinal fluid.

In summary, retinal artery macroaneurysms typically occur in elderly women with systemic hypertension, and present with a painless decrease in vision in one eye. Examination demonstrates hemorrhage at multiple levels, often with a focal, white or yellow lesion at the center of the hemorrhage, most commonly within the first few branches of the superotemporal arteriole. RAMA can typically be observed, but anti-VEGF or laser could also be considered.

Related

Retina
SHARE THIS ARTICLE :
Tweet

We would love to hear what you think! Post your questions or comments below!Cancel reply

ABOUT THE AUTHOR

eyesteve
  • ABOUT ME
  • OTHER ARTICLES
Steve Christiansen, MD, is a vitreoretinal surgeon practicing in Colorado Springs, Colorado. He previously completed ophthalmology residency at the University of Iowa Department of Ophthalmology & Visual Sciences in Iowa City, Iowa and fellowship at the Cincinnati Eye Institute in Cincinnati, Ohio.

Doctors Day 2020 – Anything But Happy

31 Mar 2020 eyesteve 1

Social Media and Professionalism – Protecting Your Patients, Your Profession, and You

30 Oct 2018 eyesteve 0

Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match

24 Oct 2018 eyesteve 0

The Retina Society – 2018 Meeting Highlights

15 Sep 2018 eyesteve 2
PREVIOUS

Ten Common Questions About Age-Related Macular Degeneration

NEXT

The Return of Private Equity to Ophthalmology

RELATED POST

Doctors Day 2020 – Anything But Happy

31 Mar 2020 eyesteve 1

Social Media and Professionalism – Protecting Your Patients, Your Profession, and You

30 Oct 2018 eyesteve 0

Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match

24 Oct 2018 eyesteve 0

The Retina Society – 2018 Meeting Highlights

15 Sep 2018 eyesteve 2

FIND EYESTEVE ON SOCIAL MEDIA

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Subscribe to EyeSteve

Latest Posts

Doctors Day 2020 – Anything But Happy

31 Mar 2020 eyesteve 11316

Social Media and Professionalism – Protecting Your Patients, Your Profession, and You

30 Oct 2018 eyesteve 8719

Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match

24 Oct 2018 eyesteve 8235

Latest Tweets From EyeSteve MD

Follow @eyesteve

EyeSteve.com Logo

EyeSteve.com was created to educate, inform, and inspire all things eye by discussing various aspects of medical education, informing patients about eye diseases and innovative new treatments, and inspiring us all toward vision health and appreciation of the wonderful gift of sight.

Recent Posts

  • Doctors Day 2020 – Anything But Happy
  • Social Media and Professionalism – Protecting Your Patients, Your Profession, and You
  • Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match
  • The Retina Society – 2018 Meeting Highlights
  • Vitreoretinal Fellowship Match Survey – JAMA Ophthalmology

Get EyeSteve In Your Email

Subscribe to eyesteve.com and receive notifications of new posts instantly by email.

Follow @eyesteve
View Steven M. Christiansen's profile on LinkedIn
Copyright 2014 | eyesteve.com | All Rights Reserved | Powered by WordPress